Neuberger Berman Group
RYTM icon

Neuberger Berman Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Neuberger Berman Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.39M Sell
73,434
-138
-0.2% -$13.4K ﹤0.01% 932
2025
Q4 		$7.88M Sell
73,572
-11,545
-14% -$1.22M 0.01% 861
2025
Q3 		$8.6M Sell
85,117
-1,022
-1% -$94.9K 0.01% 837
2025
Q2 		$5.44M Buy
86,139
+18,200
+27% +$1.11M ﹤0.01% 943
2025
Q1 		$3.6M Buy
+67,939
New +$3.77M ﹤0.01% 997

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Neuberger Berman Group's RYTM Position: Q1 2026 in Review

Neuberger Berman Group reduced its Rhythm Pharmaceuticals (RYTM) stake by 0.19% in Q1 2026, selling an estimated $13.4K and leaving 73,434 shares worth $6.39M. The position accounts for ﹤0.01% of the portfolio, ranked #932.

Neuberger Berman Group first reported a position in RYTM in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.6M in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Neuberger Berman Group held 73,434 shares of Rhythm Pharmaceuticals worth $6.39M as of Q1 2026.
  • Neuberger Berman Group sold 138 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $13.4K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #932 holding.
  • Neuberger Berman Group first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Neuberger Berman Group's Rhythm Pharmaceuticals position peaked at $8.6M in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.